Page last updated: 2024-08-17

levodopa and Heart Valve Diseases

levodopa has been researched along with Heart Valve Diseases in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (83.33)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Duong-Hua, M; Lang, A; Marras, C; Rochon, P; Sykora, K; Zadikoff, C1
Bares, M; Krajcovicová, L; Rektor, I; Rektorová, I1
Aydemir, T; Bader, H; Cetin, S; Kizkin, S; Meral, H; Ozben, B; Ozben, S; Ozer, F; Ozturk, O; Tiras, R1
Antonini, A; Calandrella, D1
Burkhard, PR; Flachsbart, KD; Fross, RD; Horvath, J; Kleiner-Fisman, G; Lang, AE; Lerch, R; Liaudat, S; Pache, JC; Rakowski, H; Raskoff, WJ; Stalder, H1
Ludin, HP1

Reviews

2 review(s) available for levodopa and Heart Valve Diseases

ArticleYear
Pharmacokinetic evaluation of pramipexole.
    Expert opinion on drug metabolism & toxicology, 2011, Volume: 7, Issue:10

    Topics: Benzothiazoles; Dopamine Agonists; Drug Delivery Systems; Drug Evaluation; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Heart Valve Diseases; Humans; Levodopa; Parkinson Disease; Pharmacogenetics; Pramipexole; Receptors, Dopamine; Restless Legs Syndrome

2011
[Are there innovations in the treatment of Parkinson's disease?].
    Praxis, 2004, Nov-03, Volume: 93, Issue:45

    Topics: Antiparkinson Agents; Cannabis; Cholinesterase Inhibitors; Controlled Clinical Trials as Topic; Dopamine Agonists; Heart Valve Diseases; Humans; Indans; Levodopa; Monoamine Oxidase Inhibitors; Neuroprotective Agents; Parkinson Disease; Pergolide; Phenylcarbamates; Placebos; Rivastigmine; Time Factors

2004

Trials

1 trial(s) available for levodopa and Heart Valve Diseases

ArticleYear
Valvular heart disease in patients with Parkinson's disease treated with pergolide, levodopa or both.
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2009, Volume: 16, Issue:1

    Topics: Adult; Aged; Analysis of Variance; Case-Control Studies; Dopamine Agonists; Drug Therapy, Combination; Echocardiography; Female; Heart Valve Diseases; Humans; Levodopa; Logistic Models; Male; Middle Aged; Parkinson Disease; Pergolide; Single-Blind Method; Young Adult

2009

Other Studies

3 other study(ies) available for levodopa and Heart Valve Diseases

ArticleYear
Pergolide associated cardiac valvulopathy based on Ontario administrative data.
    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 2008, Volume: 35, Issue:2

    Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Databases, Factual; Dopamine Agonists; Female; Health Services Administration; Heart Failure; Heart Valve Diseases; Humans; Levodopa; Male; Ontario; Parkinson Disease; Pergolide

2008
Heart valve abnormalities in Parkinson's disease treated with dopamine agonists.
    Journal of neurology, 2008, Volume: 255, Issue:10

    Topics: Antiparkinson Agents; Benzothiazoles; Dopamine Agonists; Echocardiography; Female; Heart Valve Diseases; Heart Valves; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole

2008
Severe multivalvular heart disease: a new complication of the ergot derivative dopamine agonists.
    Movement disorders : official journal of the Movement Disorder Society, 2004, Volume: 19, Issue:6

    Topics: Adult; Aged; Cabergoline; Carbidopa; Dopamine Agonists; Drug Combinations; Echocardiography, Transesophageal; Ergolines; Ergot Alkaloids; Female; Heart Valve Diseases; Humans; Levodopa; Male; Parkinson Disease; Pergolide

2004